Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Clinical trial NCT00003624 · TERMINATED

Trial details

NCT number: NCT00003624
Sponsor: Gynecologic Oncology Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Endometrial Cancer Fallopian Tube Cancer Neurotoxicity Ovarian Cancer Primary Peritoneal Cavity Cancer Sarcoma

Start date: 1998-12-01
Primary completion: 2004-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.